The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population

Código QR

The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population

Qianqian Shi, Faying Zhou, Jing Mei, Haimei Yang, Huiyun Li Department of Neurology, Daping Hospital, Army Medical University, Chongqing 400042, People’s Republic of ChinaCorrespondence: Huiyun LiDepartment of Neurology, Daping Hospital, Army Medical University, Chongqing 400042, People&am...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shi Q, Zhou F, Mei J, Yang H, Li H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	alzheimer's disease type 2 diabetes neuropsychiatric symptoms. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/3bb3d5e4e82d4b40818794645a5753fb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang YP, et al.
Publicado: (2019)

Abnormal functional connectivity of the posterior cingulate cortex is associated with depressive symptoms in patients with Alzheimer’s disease
por: Zhang J, et al.
Publicado: (2017)

Increased Prevalence of Neuropsychiatric Disorders during COVID-19 Pandemic in People Needing a Non-Deferrable Neurological Evaluation
por: Giacomo Tondo, et al.
Publicado: (2021)

The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders
por: Lai CKY
Publicado: (2014)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
por: Chen J, et al.
Publicado: (2019)

The Relationship Between Serum VCAM-1 and Alzheimer’s Disease in Patients with Type 2 Diabetes Mellitus
por: Zhang L, et al.
Publicado: (2020)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression
por: Min Zhang, et al.
Publicado: (2021)

New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia
por: Kung FC, et al.
Publicado: (2012)

Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?
por: Marc Fakhoury, et al.
Publicado: (2021)

Tauopathy and cognitive impairment in experimental diabetes mellitus
por: Mariia V. Matveeva, et al.
Publicado: (2017)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Neuropsychological dynamics in patients with type 2 diabetes mellitus undergone coronary artery bypass grafting
por: Olga Alexandrovna Trubnikova, et al.
Publicado: (2012)

Urinary excretion of type IV collagen as an early marker of renal fibrosis in patients with diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang N, et al.
Publicado: (2018)

A comprehensive review on RAGE-facilitated pathological pathways connecting Alzheimer’s disease, diabetes mellitus, and cardiovascular diseases
por: Agnila Chakraborty, et al.
Publicado: (2021)

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
por: Mar J, et al.
Publicado: (2019)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
por: Kose Ozlece H, et al.
Publicado: (2018)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Alzheimer's research & therapy
Publicado: (2009)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Effectiveness of person-centered care on people with dementia: a systematic review and meta-analysis
por: Kim SK, et al.
Publicado: (2017)

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky E, et al.
Publicado: (2016)

Associations of informant-based sleep reports with Alzheimer’s disease pathologies
por: Shokouhi S
Publicado: (2019)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease
por: Gregory A Jicha, et al.
Publicado: (2010)

Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer’s Disease
por: Li Q, et al.
Publicado: (2021)

A psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes
por: Naegeli AN, et al.
Publicado: (2010)

Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
por: Muhammad Shahid Nadeem, et al.
Publicado: (2021)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)